DESIREE STATLER: Open Payments
NPI 1245800226 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 9 payments from 6 companies in 2025. Trend: 2023 $1,047 · 2024 $688 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $178 |
| Corium, LLC | 2 | $47 |
| ABBVIE INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: INGREZZA, Azstarys, UBRELVY, BEXSERO, ABILIFY ASIMTUFII, LEQVIO, QULIPTA.
Industry payments across FL — which companies pay providers there.
